Clinical trial
Utility of Nasal Steroids for Treatment of Childhood Obstructive Sleep Apnea
NCT02180672 is registered in ClinicalTrials.gov with Children's Hospital of Philadelphia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Utility of Nasal Steroids for Treatment of Childhood Obstructive Sleep Apnea
- Lead sponsor
- Children's Hospital of Philadelphia
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- September 30, 2014
- Completion date
- October 30, 2021
- Enrollment
- 211 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
obstructive sleep apnea syndrome